We're building the leading extracellular protein degradation company leveraging our lysosomal targeting chimeras, or LYTAC, platform.

Biotechnology

Lycia Therapeutics

Lycia Therapeutics' headquarters in South San Francisco, CA, United States

Aetna Wun Trombley

Steve Staben

Karen Flick

Chin Lee

Winsome Chung

Daniel D. Von Hoff

Tim Anderson

Mark M. Davis

Alanna Schepartz

Tom Woiwode

Carolyn Bertozzi

Randy Schekman

Ming Fang

William J. Rieflin

Laurent Fischer

Clare Ozawa

The Scientific Research Team at Lycia Therapeutics drives the development and optimization of the lysosomal targeting chimeras (LYTAC) platform. This team conducts rigorous experimental research, designs and synthesizes chemical compounds, and performs detailed analyses to target and degrade extracellular proteins, advancing the company’s innovative therapeutic solutions.

Scientific Research Team

The Directors Team at Lycia Therapeutics is responsible for strategic oversight and high-level decision-making to drive the company's mission of advancing extracellular protein degradation through the LYTAC platform. They collaborate on important business objectives, manage key projects and alliances, and provide governance and independent insights to ensure the company's success.

Directors Team

The Research and Development team at Lycia Therapeutics is responsible for pioneering advancements in extracellular protein degradation through the LYTAC platform. This team orchestrates the discovery, development, and validation of innovative biologics and chemical entities, ensuring their progression from early research phases to translational and nonclinical development.

Research and Development

The Advisory Team at Lycia Therapeutics provides strategic guidance and expert insights to steer the development and implementation of our lysosomal targeting chimeras (LYTAC) platform, ensuring alignment with industry standards and advancements in extracellular protein degradation.

Advisory Team

The Leadership Team at Lycia Therapeutics is responsible for setting the strategic direction and vision of the company, guiding the development of innovative lysosomal targeting chimeras (LYTAC) therapies. This team, comprised of top executives including the President & CEO and Chief Scientific Officers, collaborates closely to drive research initiatives, ensure operational excellence, and foster partnerships that enhance the company's position as a leader in extracellular protein degradation.

Lycia Therapeutics

Org chart

Board & advisors

Teams

Scientific Research Team

Directors Team

Research and Development

Advisory Team

Leadership Team

Offices

Lycia Therapeutics

Org chart

Board & advisors

Teams

Scientific Research Team

Directors Team

Research and Development

Advisory Team

Leadership Team

Offices

Related companies